Rational Design and Characterization of Trispecific Antibodies Targeting the HIV-1 Receptor and Envelope Glycoprotein

被引:1
作者
Liang, Jinhu [1 ]
Zhai, Linlin [2 ]
Liang, Zuxin [2 ]
Chen, Xiaoling [2 ]
Jiang, Yushan [2 ]
Lin, Yuanlong [1 ]
Feng, Shiyan [1 ]
Liu, Yingxia [1 ]
Zhao, Wei [2 ]
Wang, Fuxiang [1 ]
机构
[1] Southern Univ Sci & Technol, Hosp 2, Shenzhen Peoples Hosp 3, Shenzhen Key Lab Pathogen & Immun,Natl Clin Res Ct, Shenzhen 518112, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Sch Publ Hlth, Dept Lab Med,Guangdong Prov Key Lab Trop Dis Res,B, 1023 South Shatai Rd, Baiyun Dist, Guangzhou 510515, Peoples R China
基金
中国国家自然科学基金;
关键词
HIV-1; neutralizing antibodies; trispecific antibodies; host receptor CD4; CCR5; NEUTRALIZING ANTIBODIES; BISPECIFIC ANTIBODIES; MONOCLONAL-ANTIBODY; POTENT; INHIBITION; BROAD; IDENTIFICATION; IBALIZUMAB;
D O I
10.3390/vaccines12010019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multitudinous broadly neutralizing antibodies (bNAbs) against HIV-1 have been developed as novel antiviral prophylactic and therapeutic agents. Combinations of bNAbs are generally even more effective than when they are applied individually, showing excellent neutralization coverage and limiting the emergence of escape mutants. In this study, we investigated the design and characterization of three trispecific antibodies that allow a single molecule to interact with independent HIV-1 envelope determinants-(1) the host receptor CD4, (2) the host co-receptor CCR5 and (3) distinct domains in the envelope glycoprotein of HIV-1-using an ELISA, an HIV-1 pseudovirus neutralization assay and in vivo antiviral experiments in humanized mice. We found that trispecific bNAbs and monovalent ones all had satisfactory binding activities against the corresponding antigens in the ELISA, exhibited higher potency and breadth than any previously described single bnAb in the HIV-1 pseudovirus neutralization assay and showed an excellent antiviral effect in vivo. The trispecific antibodies simultaneously recognize the host receptor CD4, host co-receptor CCR5 and HIV-1 envelope glycoprotein, which could mean they have promise as prophylactic and therapeutic agents against HIV-1.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] HIV-1 vaccine design through minimizing envelope metastability
    He, Linling
    Kumar, Sonu
    Allen, Joel D.
    Huang, Deli
    Lin, Xiaohe
    Mann, Colin J.
    Saye-Francisco, Karen L.
    Copps, Jeffrey
    Sarkar, Anita
    Blizard, Gabrielle S.
    Ozorowski, Gabriel
    Sok, Devin
    Crispin, Max
    Ward, Andrew B.
    Nemazee, David
    Burton, Dennis R.
    Wilson, Ian A.
    Zhu, Jiang
    SCIENCE ADVANCES, 2018, 4 (11):
  • [22] Monoclonal antibodies to host cellular receptors for the treatment and prevention of HIV-1 infection
    Pace, Craig
    Markowitz, Martin
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (03) : 144 - 150
  • [23] Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs
    Witt, Kristen C.
    Castillo-Menendez, Luis
    Ding, Haitao
    Espy, Nicole
    Zhang, Shijian
    Kappes, John C.
    Sodroski, Joseph
    PLOS ONE, 2017, 12 (02):
  • [24] Neutralizing antibodies for HIV-1 prevention
    Julg, Boris
    Barouch, Dan H.
    CURRENT OPINION IN HIV AND AIDS, 2019, 14 (04) : 318 - 324
  • [25] Monoclonal antibodies to an HIV-1 group O envelope recombinant
    Scheffel, JW
    Ziemann, R
    Hawksworth, D
    Tyner, J
    Hickman, RK
    Hackett, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 22 (03): : 221 - 227
  • [26] HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation
    Checkley, Mary Ann
    Luttge, Benjamin G.
    Freed, Eric O.
    JOURNAL OF MOLECULAR BIOLOGY, 2011, 410 (04) : 582 - 608
  • [27] Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro
    Ozorowski, Gabriel
    Cupo, Albert
    Golabek, Michael
    LoPiccolo, Michelle
    Ketas, Thomas A.
    Cavallary, Matt
    Cottrell, Christopher A.
    Klasse, P. J.
    Ward, Andrew B.
    Moore, John P.
    JOURNAL OF VIROLOGY, 2018, 92 (13)
  • [28] The role of matrix in HIV-1 envelope glycoprotein incorporation
    Tedbury, Philip R.
    Freed, Eric O.
    TRENDS IN MICROBIOLOGY, 2014, 22 (07) : 372 - 378
  • [29] Characterization of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformational States on Infectious Virus Particles
    Nguyen, Hanh T.
    Wang, Qian
    Anang, Saumya
    Sodroski, Joseph G.
    JOURNAL OF VIROLOGY, 2023, 97 (03) : e0185722
  • [30] Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression
    Valenzuela-Fernandez, Agustin
    Cabrera-Rodriguez, Romina
    Casado, Concha
    Perez-Yanes, Silvia
    Pernas, Maria
    Garcia-Luis, Jonay
    Marfil, Silvia
    Olivares, Isabel
    Estevez-Herrera, Judith
    Trujillo-Gonzalez, Rodrigo
    Blanco, Julia
    Lopez-Galindez, Cecilio
    BIOMEDICINES, 2022, 10 (09)